| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Class A common stock | 14,546 | $2,502,281 | $172.03 | 09 Jun 2021 | Direct |
| REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Employee Stock Option (right to buy) | 9,934 | 09 Jun 2021 | Direct | ||
| REATA PHARMACEUTICALS INC | VP, Chief Accounting Officer | Class B common stock | 0 | $172.03 | 09 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919121039175-castellanos-elaine-2021-06-07 | REATA PHARMACEUTICALS INC | 07 Jun 2021 | 12 | -$1,200,813 | 4 | VP, Chief Accounting Officer | 09 Jun 2021, 16:28 |
| /report/000120919121036326-castellanos-elaine-2021-05-26 | REATA PHARMACEUTICALS INC | 26 May 2021 | 7 | -$1,053,716 | 4 | VP, Chief Accounting Officer | 27 May 2021, 18:15 |